Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

FISH and SNP-Array Karyotyping Improve the Detection of Recurrent Chromosomal Defects Including Del(5q), Monosomy 7, Del(7q), Trisomy 8, and Del(20q) in Myelodysplastic Syndromes.

Hideki Makishima, MD, PhD, Manjot Rataul, MD, Lukasz P. Gondek, MD, PhD, Jungwon Huh, MD, James R. Cook, MD, PhD, Karl S. Theil, MD, Mikkael A Sekeres, MD, MS, Elizabeth Kuczkowski, Jaroslaw P. Maciejewski, MD, PhD

Blood (2008) 112 (11): 1483.

https://doi.org/10.1182/blood.V112.11.1483.1483

Published: 2008

Journal Articles

A Quality of Life Assessment of Ablative Allogeneic Bone Marrow Transplant (BMT) Recipients One and Twelve Months after Transplant.

Brian Bolwell, MD, Linda McLellan, LISW, Larry Foster, Ph.D, Lisa Rybicki, Ronald M. Sobecks, MD, Brad Pohlman, MD, Steve Andresen, DO, Elizabeth Kuczkowski, Mary Serafin, R.N., Karen Sands, R.N., Jennifer Kosar, R.N., Stacey Brown, Jennifer Bates, Mikkael Sekeres, MD, MS, Jane Dabney, LISW, Erin Welsh, LSW, Matt Kalaycio, MD

Blood (2005) 106 (11): 1322.

https://doi.org/10.1182/blood.V106.11.1322.1322

Published: 2005

Journal Articles

Autologous Stem Cell Transplantation (ABMT) for Recurrent Hodgkin’s Disease from 1990–2005: Factors Contributing to Post-Transplant Relapse.

Brian Bolwell, MD, Brad Pohlman, MD, Matt Kalaycio, MD, Steve Andresen, DO, Elizabeth Kuczkowski, Stacey Brown, Jennifer Bates, Lisa Rybicki, Julie Curtis, R.N., Kimberly Bell, R.N., Ronald M. Sobecks, MD

Blood (2005) 106 (11): 2083.

https://doi.org/10.1182/blood.V106.11.2083.2083

Published: 2005

Journal Articles

Cytogenetic Classification Systems and Overall Survival Following Bone Marrow Transplant (BMT) for Acute Myelogenous Leukemia (AML).

Matt Kalaycio, MD, Mikkael Sekeres, MD, Ronald Sobecks, MD, Lisa Rybicki, Brad Pohlman, MD, Anjali Advani, MD, Elizabeth Kuczkowski, Brian Bolwell, MD

Blood (2005) 106 (11): 4500.

https://doi.org/10.1182/blood.V106.11.4500.4500

Published: 2005

Journal Articles

Tandem Autologous Stem Cell Transplantation for Patients with Primary Progressive or Rapidly Relapsing Hodgkin’s Disease.

Brian Bolwell, MD, Brad Pohlman, MD, Ronald Sobecks, MD, Steven Andresen, DO, Lisa Rybicki, Stacey Brown, Elizabeth Kuczkowski, Jennifer Bates, Laura Bernhard, R.N., Kelly Cherni, R.N., Janet Baker, R.N., Matt Kalaycio, M.D.

Blood (2005) 106 (11): 5482.

https://doi.org/10.1182/blood.V106.11.5482.5482

Published: 2005

Journal Articles

Pulmonary Mortality after High-Dose Oral Busulfan and Autologous Stem Cell Transplant (ASCT) in Patients with Non-Hodgkin Lymphoma (NHL).

Matt Kalaycio, MD, Brad Pohlman, MD, Lisa Rybicki, Ronald Sobecks, MD, Elizabeth Kuczkowski, Steven Andresen, DO, Stacey Brown, Brian Bolwell, MD

Blood (2005) 106 (11): 1764.

https://doi.org/10.1182/blood.V106.11.1764.1764

Published: 2005

Journal Articles

Final Analysis of a Randomized, Phase III, Trial Using Etoposide and G-CSF with or without Rituximab (R) for Peripheral Stem Cell Mobilization (PSC) in B-Cell Non-Hodgkin Lymphoma (B-NHL).

Brad Pohlman, MD, Lisa Rybicki, MS, Elizabeth Kuczkowski, Stacey Brown, Matt Kalaycio, MD, Ronald Sobecks, MD, Steven Andresen, MD, Brian J. Bolwell, MD

Blood (2005) 106 (11): 300.

https://doi.org/10.1182/blood.V106.11.300.300

Published: 2005

Journal Articles

Very High Hospital Admission Rate after Outpatient Non-Myeloablative Allogeneic Stem Cell Transplant Using Fludarabine and Low Dose TBI.

Brian Bolwell, MD, Lisa Rybicki, Matt Kalaycio, MD, Brad Pohlman, MD, Steven Andresen, DO, Stacey Brown, Elizabeth Kuczkowski, Jennifer Bates, Laura Bernhard, R.N., Kelly Cherni, R.N., Janet Baker, R.N., Ronald Sobecks, MD

Blood (2005) 106 (11): 3667.

https://doi.org/10.1182/blood.V106.11.3667.3667

Published: 2005

Journal Articles

Improved Post-Transplant Outcomes in Hematologic Malignancy Patients Undergoing Non-Myeloablative Hematopoietic Stem Cell Transplant (NMHSCT) Using a 400 cGy Total Body Irradiation (TBI) Dose with Fludarabine.

Ronald M. Sobecks, MD, Karl S. Theil, MD, Lisa Rybicki, Roger Macklis, MD, Brad Pohlman, MD, Steve Andresen, DO, Stacey Brown, Elizabeth Kuczkowski, Kelly Cherni, R.N., Janet Baker, R.N., Laura Bernhard, R.N., Matt Kalaycio, MD, Brian Bolwell, MD

Blood (2005) 106 (11): 3674.

https://doi.org/10.1182/blood.V106.11.3674.3674

Published: 2005

Journal Articles

Platelet Engraftment (PE) in AML Patients Receiving HLA Matched Sibling Donor Allogeneic Bone Marrow Transplant (ABMT) Correlates with Inhibitory HLA Ligand Groups for Killer Immunoglobulin-Like Receptors (KIRs).

Ronald Sobecks, Edward J. Ball, Lisa Rybicki, Stacey Brown, Jaroslaw Maciejewski, Matt Kalaycio, Brad Pohlman, Elizabeth Kuczkowski, Julie Curtis, Brian Bolwell

Blood (2005) 106 (11): 836.

https://doi.org/10.1182/blood.V106.11.836.836

Published: 2005

Journal Articles

Severe Mucositis Adversely Affects Survival after Autologous Stem Cell Transplantation (ABMT) for Lymphoid Malignancies.

Brian Bolwell, MD, Matt Kalaycio, MD, Ronald Sobecks, MD, Steven Andresen, DO, Lisa Rybicki, Elizabeth Kuczkowski, Sherry Mendiola, Joe Kohuth, Kimberly Bell, R.N., Julie Curtis, R.N., Stacey Brown, Brad Pohlman, MD

Blood (2005) 106 (11): 837.

https://doi.org/10.1182/blood.V106.11.837.837

Published: 2005

Journal Articles

Non-Myeloablative vs. Conventional Allogeneic Hematopoietic Stem Cell Transplantation for Lymphoma.

Brad Pohlman, MD, Tao Jin, MS, Elizabeth Kuczkowski, Stacey Brown, Ronald Sobecks, MD, Matt Kalaycio, MD, Steven Andresen, MD, Brian J. Bolwell, MD

Blood (2005) 106 (11): 1132.

https://doi.org/10.1182/blood.V106.11.1132.1132

Published: 2005

Journal Articles

High Dose Therapy with Autologous Blood Stem Cell Transplantation (Asct) for Relapsed, Follicular Lymphoma (FL) vs. De Novo, Diffuse Large B-Cell (dnDLBL) vs. Transformed, Follicular To Diffuse Large B-Cell Lymphoma (Tdlbl): No Difference in Freedom from Progression.

Brad Pohlman, M.D., Tony Jin, Kristie Summers, Elizabeth Kuczkowski, Stacey Brown, Matt Kalaycio, M.D., Ronald Sobecks, M.D., Steven Andresen, D.O., Laura Bernhard, R.N., Kelly Cherni, R.N., Janet Baker, R.N., Brian J. Bolwell, M.D.

Blood (2004) 104 (11): 1880.

https://doi.org/10.1182/blood.V104.11.1880.1880

Published: 2004

Journal Articles

Improved Outcomes with Class I and II DNA-Based HLA Typing for Matched Unrelated Donor (MUD) Allogeneic Bone Marrow Transplant (ABMT) in Hematologic Diseases.

Ronald Sobecks, M.D., Edward J. Ball, PhD, Lisa Rybicki, Elizabeth Kuczkowski, Matt Kalaycio, M.D., Brad Pohlman, M.D., Steven Andresen, D.O., Karen Sands, R.N., Jennifer Kosar, R.N., Mary Serafin, R.N., Jennifer Bates, Christy Lalli, Brian Bolwell, M.D.

Blood (2004) 104 (11): 5181.

https://doi.org/10.1182/blood.V104.11.5181.5181

Published: 2004

Journal Articles

A Psychosocial Assessment of Patients before and after Autologous Stem Cell Transplantation.

Brian J. Bolwell, M.D., Linda McLellan, LISW, Larry Foster, Ph.D, Jane Dabney, LISW, Erin Welsh, LISW, Elizabeth Kuczkowski, Julie Curtis, R.N., Kimberly Bell, R.N., Janet Baker, R.N., Laura Bernhard, R.N., Kelly Cherni, R.N., Lisa Rybicki, Mikkael A. Sekeres, M.D, M.S.

Blood (2004) 104 (11): 3152.

https://doi.org/10.1182/blood.V104.11.3152.3152

Published: 2004

Journal Articles

Outcomes Analysis of Patients Surviving ≥2 Years after Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT).

Ronald Sobecks, M.D., Matt Kalaycio, M.D., Brad Pohlman, M.D., Steven Andresen, D.O., Lisa Rybicki, Jennifer Kosar, R.N., Mary Serafin, R.N., Karen Sands, R.N., Christy Lalli, Stacey Brown, Elizabeth Kuczkowski, Brian Bolwell, M.D.

Blood (2004) 104 (11): 2762.

https://doi.org/10.1182/blood.V104.11.2762.2762

Published: 2004

Journal Articles

The Kinetics of Etoposide (VP-16) Peripheral Blood Progenitor Cell (PBPC) Mobilization.

Brian J. Bolwell, M.D., Elizabeth Kuczkowski, Lisa Rybicki, Brad Pohlman, M.D., Steven Andresen, D.O., Ronald Sobecks, M.D., Janet Baker, R.N., Kelly Cherni, R.N., Laura Bernhard, R.N., Alison Vellani, Nicole Berry, Shawnda Sungren, Leslie Foster, Matt Kalaycio, M.D.

Blood (2004) 104 (11): 4993.

https://doi.org/10.1182/blood.V104.11.4993.4993

Published: 2004

Journal Articles

Psychosocial Factors in Decision-Making of Patient Eligibility for Allogeneic Bone Marrow Transplantation.

Brian J. Bolwell, M.D., Linda McLellan, LISW, Elizabeth Kuczkowski, Jane Dabney, LISW, Victoria Wentling, Brad Pohlman, M.D., Ronald Sobecks, M.D., Steven Andresen, D.O., Matt Kalaycio, M.D., Bridget Rini, Julie Curtis, R.N., Larry W. Foster, PhD, Mikkael A. Sekeres, M.D., M.S.

Blood (2004) 104 (11): 3324.

https://doi.org/10.1182/blood.V104.11.3324.3324

Published: 2004

Journal Articles

High Dose Therapy with Autologous Blood Stem Cell Transplantation (ASCT) for Follicular Lymphoma: Long-Term Outcome According to Histologic Grade.

Brad Pohlman, M.D., Tony Jin, Kristie Summers, Elizabeth Kuczkowski, Matt Kalaycio, M.D., Ronald Sobecks, M.D., Steven Andresen, D.O., Laura Bernhard, R.N., Kelly Cherni, R.N., Janet Baker, R.N., Jennifer Bates, Brian J. Bolwell, M.D.

Blood (2004) 104 (11): 896.

https://doi.org/10.1182/blood.V104.11.896.896

Published: 2004

Journal Articles

The Prognostic Importance of Pre and Post Dendritic Cells in Autologous Transplantation for Diffuse Large B Cell Lymphoma.

Brian J. Bolwell, M.D., Brad Pohlman, M.D., Steve Andresen, D.O., Sheila Serafino, Ronald Sobecks, M.D., Elizabeth Kuczkowski, Julie Curtis, R.N., Lisa Rybicki, Jarek Maciejewski, M.D., PhD, Janet Baker, R.N., Kelly Cherni, R.N., Laura Bernhard, R.N., Matt Kalaycio, M.D., Eric Hsi, M.D., Karl Theil, M.D.

Blood (2004) 104 (11): 443.

https://doi.org/10.1182/blood.V104.11.443.443

Published: 2004

NARROW

FISH and SNP-Array Karyotyping Improve the Detection of Recurrent Chromosomal Defects Including Del(5q), Monosomy 7, Del(7q), Trisomy 8, and Del(20q) in Myelodysplastic Syndromes.

A Quality of Life Assessment of Ablative Allogeneic Bone Marrow Transplant (BMT) Recipients One and Twelve Months after Transplant.

Autologous Stem Cell Transplantation (ABMT) for Recurrent Hodgkin’s Disease from 1990–2005: Factors Contributing to Post-Transplant Relapse.

Cytogenetic Classification Systems and Overall Survival Following Bone Marrow Transplant (BMT) for Acute Myelogenous Leukemia (AML).

Tandem Autologous Stem Cell Transplantation for Patients with Primary Progressive or Rapidly Relapsing Hodgkin’s Disease.

Pulmonary Mortality after High-Dose Oral Busulfan and Autologous Stem Cell Transplant (ASCT) in Patients with Non-Hodgkin Lymphoma (NHL).

Final Analysis of a Randomized, Phase III, Trial Using Etoposide and G-CSF with or without Rituximab (R) for Peripheral Stem Cell Mobilization (PSC) in B-Cell Non-Hodgkin Lymphoma (B-NHL).

Very High Hospital Admission Rate after Outpatient Non-Myeloablative Allogeneic Stem Cell Transplant Using Fludarabine and Low Dose TBI.

Improved Post-Transplant Outcomes in Hematologic Malignancy Patients Undergoing Non-Myeloablative Hematopoietic Stem Cell Transplant (NMHSCT) Using a 400 cGy Total Body Irradiation (TBI) Dose with Fludarabine.

Platelet Engraftment (PE) in AML Patients Receiving HLA Matched Sibling Donor Allogeneic Bone Marrow Transplant (ABMT) Correlates with Inhibitory HLA Ligand Groups for Killer Immunoglobulin-Like Receptors (KIRs).

Severe Mucositis Adversely Affects Survival after Autologous Stem Cell Transplantation (ABMT) for Lymphoid Malignancies.

Non-Myeloablative vs. Conventional Allogeneic Hematopoietic Stem Cell Transplantation for Lymphoma.

High Dose Therapy with Autologous Blood Stem Cell Transplantation (Asct) for Relapsed, Follicular Lymphoma (FL) vs. De Novo, Diffuse Large B-Cell (dnDLBL) vs. Transformed, Follicular To Diffuse Large B-Cell Lymphoma (Tdlbl): No Difference in Freedom from Progression.

Improved Outcomes with Class I and II DNA-Based HLA Typing for Matched Unrelated Donor (MUD) Allogeneic Bone Marrow Transplant (ABMT) in Hematologic Diseases.

A Psychosocial Assessment of Patients before and after Autologous Stem Cell Transplantation.

Outcomes Analysis of Patients Surviving ≥2 Years after Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT).

The Kinetics of Etoposide (VP-16) Peripheral Blood Progenitor Cell (PBPC) Mobilization.

Psychosocial Factors in Decision-Making of Patient Eligibility for Allogeneic Bone Marrow Transplantation.

High Dose Therapy with Autologous Blood Stem Cell Transplantation (ASCT) for Follicular Lymphoma: Long-Term Outcome According to Histologic Grade.

The Prognostic Importance of Pre and Post Dendritic Cells in Autologous Transplantation for Diffuse Large B Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only